Switching Off Bacterial Resistance
Bioversys AG is a privately held Swiss biopharmaceutical company located in Basel that focuses on research and development of new drugs and compounds, which switch off drug resistance within bacterial pathogens and restore the efficacy of approved antibiotics. Spun out of the ETH-Zurich in 2008, we have profound technological expertise that is based on solid IP.
BioVersys is a dynamic, innovative and knowledge-driven startup company. We are constantly looking for talented and self-motivated people that would like to work in the multitasking environment of a start-up Company.